BiotechTube

Agalsidase beta + Agalsidase beta

Phase 3Completed
0 views this week 0 watching⚡ Active
Interest: 40/100
40
Hype Score

Development Stage

✓
Pre-clinical
✓
Phase 1
✓
Phase 2
4
Phase 3
5
Approved
Indication / Disease

Fabry Disease

Conditions

Fabry Disease

Trial Timeline

Sep 1, 2008 → Jun 1, 2015

NCT ID
NCT00701415

About Agalsidase beta + Agalsidase beta

Agalsidase beta + Agalsidase beta is a phase 3 stage product being developed by Sanofi for Fabry Disease. The current trial status is completed. This product is registered under clinical trial identifier NCT00701415. Target conditions include Fabry Disease.

What happened to similar drugs?

9 of 20 similar drugs in Fabry Disease were approved

Approved (9) Terminated (4) Active (10)
✅agalsidase betaSanofiApproved
✅Fabrazyme (agalsidase beta)SanofiApproved
✅agalsidase betaSanofiApproved
✅AGALSIDASE BETA (GZ419828) + Acetaminophen + Diphenhydramine + Dexamethasone + Montelukast + Loratadine + Cetirizine + FexofenadineSanofiApproved
✅Agalsidase betaSanofiApproved
✅agalsidase beta (GZ419828) + agalsidase alfaSanofiApproved
✅Agalsidase betaSanofiApproved

Hype Score Breakdown

Clinical
17
Activity
8
Company
15
Novelty
0
Community
0

Clinical Trials (1)

NCT IDPhaseStatus
NCT00701415Phase 3Completed

Competing Products

20 competing products in Fabry Disease

See all competitors
ProductCompanyStageHype Score
LucerastatIdorsiaPhase 3
38
Fabrazyme (agalsidase beta)SanofiPhase 2
35
Venglustat (GZ402671) + PlaceboSanofiPhase 3
44
Fabrazyme (agalsidase beta) + Fabrazyme (agalsidase beta)SanofiPhase 2
27
agalsidase betaSanofiApproved
35
TropicamideSanofiPre-clinical
26
Fabrazyme (agalsidase beta)SanofiApproved
35
agalsidase betaSanofiApproved
43
AGALSIDASE BETA (GZ419828) + Acetaminophen + Diphenhydramine + Dexamethasone + Montelukast + Loratadine + Cetirizine + FexofenadineSanofiApproved
43
Gabapentin + placeboSanofiPhase 2
27
Agalsidase betaSanofiApproved
43
GZ/SAR402671SanofiPhase 2
35
agalsidase beta (GZ419828) + agalsidase alfaSanofiApproved
35
Fabrazyme (agalsidase beta)SanofiPhase 3
40
Venglustat (GZ402671) + Agalsidase alfa + Agalsidase beta (GZ419828) + MigalastatSanofiPhase 3
44
IohexolSanofiPhase 1
21
GZ/SAR402671SanofiPhase 2
35
Fabrazyme (agalsidase beta)SanofiPhase 2
35
Agalsidase betaSanofiApproved
43
Fabrazyme (agalsidase beta) + PlaceboSanofiApproved
43